Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology

SA Kozek-Langenecker, A Afshari… - European Journal of …, 2013‏ - journals.lww.com
The aims of severe perioperative bleeding management are three-fold. First, preoperative
identification by anamesis and laboratory testing of those patients for whom the …

[HTML][HTML] Platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function

CPM Hayward, P Harrison, M Cattaneo, TL Ortel… - Journal of Thrombosis …, 2006‏ - Elsevier
Summary Background: Closure time (CT), measured by platelet function analyzer (PFA‐
100®) device, is now available to the clinical laboratory as a possible alternative or …

Stop** vs. continuing aspirin before coronary artery surgery

PS Myles, JA Smith, A Forbes, B Silbert… - … England Journal of …, 2016‏ - Mass Medical Soc
Background Most patients with coronary artery disease receive aspirin for primary or
secondary prevention of myocardial infarction, stroke, and death. Aspirin poses a risk of …

Peri-operative management of antiplatelet therapy in patients with coronary artery disease

W Korte, M Cattaneo, PG Chassot… - Thrombosis and …, 2011‏ - thieme-connect.com
An increasing number of patients suffering from cardiovascular disease, especially coronary
artery disease (CAD), are treated with aspirin and/or clopidogrel for the prevention of major …

A multiple dose study of prasugrel (CS‐747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans

JA Jakubowski, N Matsushima, F Asai… - British journal of …, 2007‏ - Wiley Online Library
Aims This double‐blind, placebo‐controlled trial was designed to evaluate the
pharmacodynamics, pharmacokinetics, safety, and tolerability of prasugrel (CS‐747 …

Acquired disorders of platelet function

BA Konkle - Hematology 2010, the American Society of …, 2011‏ - ashpublications.org
Platelet dysfunction is commonly acquired due to medications, procedures, medical
conditions, and underlying hematologic disease. These issues are presented, the data …

Perioperative antiplatelet therapy

PG Chassot, C Marcucci, A Delabays… - American family …, 2010‏ - aafp.org
Aspirin is recommended as a lifelong therapy that should never be interrupted for patients
with cardiovascular disease. Clopidogrel therapy is mandatory for six weeks after placement …

Whole blood multiple electrode aggregometry is a reliable point-of-care test of aspirin-induced platelet dysfunction

C Jámbor, CF Weber, K Gerhardt, W Dietrich… - Anesthesia & …, 2009‏ - journals.lww.com
BACKGROUND: Aspirin is one of the most commonly ingested over-the-counter drugs. In
addition to its analgesic and antiinflammatory actions, it also potently inhibits platelet …

Does antiplatelet therapy affect outcomes of patients receiving abdominal laparoscopic surgery? Lessons from more than 1,000 laparoscopic operations in a single …

T Fujikawa, A Tanaka, T Abe, Y Yoshimoto… - Journal of the American …, 2013‏ - Elsevier
Background The effect of antiplatelet therapy (APT) on surgical blood loss and perioperative
complications in patients receiving abdominal laparoscopic surgery still remains unclear …

[HTML][HTML] Recovery time of platelet function after aspirin withdrawal

J Lee, JK Kim, JH Kim, T Dunuu, SH Park… - Current Therapeutic …, 2014‏ - Elsevier
Introduction Inappropriate antiplatelet therapy discontinuation increases the risk of
thrombotic complications and bleeding after dental procedures. To determine the platelet …